A Microdose Evaluation Study of ABY-029 in Recurrent Glioma
Clinical trial NCT02901925 · COMPLETED
Trial details
- NCT number
- NCT02901925
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2021-06-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.